Vaxneuvance is a pneumococcal 15-valent conjugate vaccine (PCV15) designed to protect against serious infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, and bloodstream infections. Recommended for children and adults aged 19 and older—particularly those with risk factors—Vaxneuvance provides targeted immunity against 15 strains of pneumococcal bacteria. Often administered as part of a vaccination series, it may be followed by PPSV23 for broader protection. Consult your healthcare provider to determine if Vaxneuvance is appropriate for your immunization needs and schedule.
